Stock Reports Archives

Psychedelic Business Spotlight: August 13, 2021

This week in psychedelic business news: Psychedelics in development to treat eye diseases and stroke; companies gear up for new clinical trials investigating psychedelics for general anxiety, chronic pain, and eating disorders.

Psychedelic Spotlight Business Round Up July 30

Psychedelic Business Spotlight: July 30, 2021

Business, Stock Reports

This week in psychedelic business news: More psychedelic-assisted therapy clinics, recruitment begins in early DMT trial, and Filament gets more Health Canada love.

Psychedelic Business Spotlight: July 23, 2021

Business, Stock Reports

This week in psychedelic business news: Psychedelics as a treatment for obesity and TBIs, plus another psychedelic company inches toward listing on NYSE American stock exchange.

Psychedelic Business Spotlight: July 16, 2021

Business, Stock Reports

This week in psychedelic business news: A generous donation to advance MDMA research, psilocybin for end-of-life anxiety, and provisional patents filed for synthesizing ibogaine.

Psychedelic Business Spotlight: July 9, 2021

Business, Stock Reports

This week in psychedelic business news: It’s all about partnerships and acquisitions designed to advance psychedelic therapies for depression, suicidal ideation, pain, and more.

Psychedelic Business Spotlight: July 2, 2021

Business, Stock Reports

This week in psychedelic business news: Companies embrace the psychedelic aspects of VR, Braxia trains therapists in psychedelic best practices, and Allied gears up to provide its psychedelic formulation to PTSD patients.

Psychedelic Business Spotlight: June 25, 2021

Business, Stock Reports

This week in psychedelic business news: A next-gen psychedelic for stroke care, a major merger, and two more companies list on NEO Exchange.

Psychedelic Business Spotlight: June 18, 2021

Business, Stock Reports

This week in psychedelic business news: Patent progress for biosynthetic psilocybin, psychedelics for brain health, and psychedelic and cannabis companies team up in the name of research.